Published in Cancer Causes Control on August 01, 1999
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer (2010) 1.52
An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer (2005) 1.29
Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17
Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer (2011) 1.03
Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study. Cancer Epidemiol Biomarkers Prev (2010) 0.97
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause (2008) 0.97
Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition. PLoS One (2012) 0.96
Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res (2008) 0.95
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Res (2005) 0.94
BMSCs reduce rat granulosa cell apoptosis induced by cisplatin and perimenopause. BMC Cell Biol (2013) 0.93
Progesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapies. Breast Cancer Res (2002) 0.87
Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. BMC Genomics (2014) 0.86
Hormone replacement therapy and the breast. BMJ (2001) 0.84
The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients. Eur J Cancer (2009) 0.82
Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes. Glia (2014) 0.82
Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors. Cancer Biol Ther (2016) 0.80
The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α. PLoS One (2011) 0.79
Estrogen-like activity of aqueous extract from Agrimonia pilosa Ledeb. in MCF-7 cells. BMC Complement Altern Med (2012) 0.76
Perspectives of breast cancer etiology: synergistic interaction between smoking and exogenous hormone use. Chin J Cancer (2011) 0.75
Moxibustion Reduces Ovarian Granulosa Cell Apoptosis Associated with Perimenopause in a Natural Aging Rat Model. Evid Based Complement Alternat Med (2015) 0.75
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol (1985) 11.38
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst (1995) 5.35
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Stressful life events and Graves' disease. Lancet (1991) 3.63
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Systematic biases in functional status assessment of elderly adults: effects of different data sources. J Gerontol (1984) 2.77
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
A prospective study of diet quality and mortality in women. JAMA (2000) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Chronic pain 5 years after randomized comparison of laparoscopic and Lichtenstein inguinal hernia repair. Br J Surg (2010) 2.39
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med (2007) 2.12
Venous thromboembolism and cancer. Lancet (1998) 2.08
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst (1995) 2.03
Causes of false-negative sentinel node biopsy in patients with breast cancer. Br J Surg (2013) 1.99
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Preventing excessive weight gain during pregnancy - a controlled trial in primary health care. Eur J Clin Nutr (2007) 1.91
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90
Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer (2004) 1.88
Observed and relative survival after aortic valve replacement. J Am Coll Cardiol (2000) 1.86
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Surgical anatomy of human parathyroid glands. Surgery (1984) 1.81
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
[Longitudinal study of the mother and child population in an urban region of southern Brazil, 1993: methodological aspects and preliminary results]. Rev Saude Publica (1996) 1.74
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Evidence of a healthy estrogen user survivor effect. Epidemiology (1995) 1.72
Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer (2005) 1.71
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J (2000) 1.68
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Int J Cancer (1996) 1.66
Sternal wound complications--incidence, microbiology and risk factors. Eur J Cardiothorac Surg (1997) 1.66
Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med (2001) 1.59
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery (1987) 1.56
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.56
Prevalence and trends of sunscreen use and sunburn among Norwegian women. Br J Dermatol (2014) 1.54
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer (2006) 1.53
International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer (1997) 1.50
Risk of cancer in women receiving hormone replacement therapy. Int J Cancer (1989) 1.49
Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer (2001) 1.49
Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord (1992) 1.49
Papanicolaou smear screening and cervical cancer. What can you expect? JAMA (1984) 1.48
Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int (1993) 1.48
Human fertility does not decline: evidence from Sweden. Fertil Steril (1999) 1.47
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Long-term trends in incidence of and mortality from acute myocardial infarction and stroke in women: Analyses of total first events and of deaths in the Uppsala Health Care Region, Sweden. Epidemiology (1996) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44
Nurse or surgeon follow-up after rectal cancer: a randomized trial. Colorectal Dis (2010) 1.44
Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet (1987) 1.42
Collaboration between developing and developed countries and between developing countries in occupational health research and surveillance. Scand J Work Environ Health (1999) 1.41
Environmental risk factors of breast cancer. Scand J Work Environ Health (1998) 1.40
Melanoma in pregnancy. Lancet (1991) 1.39
Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer (2005) 1.39
Pacifier use and short breastfeeding duration: cause, consequence, or coincidence? Pediatrics (1997) 1.39
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ (1989) 1.39
Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol (1989) 1.38
Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control (2001) 1.37
Alcohol abuse and the risk of pancreatic cancer. Gut (2002) 1.35
Menstrual factors and risk of breast cancer. Cancer Invest (1988) 1.34
Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol (1996) 1.34
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer (2001) 1.33
Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer (1999) 1.33
Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am J Epidemiol (1999) 1.32
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol (1992) 1.32
A prospective study of menopausal hormones and risk of colorectal cancer (United States) Cancer Causes Control (1997) 1.30
Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin Chim Acta (2004) 1.30
An introduction to epidemiological research with medical databases. Ann Epidemiol (2000) 1.27